{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:48:41Z","timestamp":1717030121721},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1093\/jac\/44.6.827","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:24:55Z","timestamp":1027707895000},"page":"827-829","source":"Crossref","is-referenced-by-count":7,"title":["In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans"],"prefix":"10.1093","volume":"44","author":[{"given":"Mohammad Ashraf","family":"Hossain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigefumi","family":"Maesaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Mitsutake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Tomono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,12]]},"reference":[{"key":"key\n\t\t\t\t20170411034910_R1","doi-asserted-by":"crossref","unstructured":"Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R. & Scully, C. (1995). Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Journal of Antimicrobial Chemotherapy35, 103\u201314.","DOI":"10.1093\/jac\/35.1.103"},{"key":"key\n\t\t\t\t20170411034910_R2","doi-asserted-by":"crossref","unstructured":"Lamb, D. C., Corran, A., Baldwin, B. C., Kwon-Chung, J. & Kelly, S. L. (1995). Resistant P45091A1 activity in azole antifungal tolerant. Cryptococcus neoformans from AIDS patients. FEBS Letters368, 326\u201330.","DOI":"10.1016\/0014-5793(95)00684-2"},{"key":"key\n\t\t\t\t20170411034910_R3","doi-asserted-by":"crossref","unstructured":"Galgiani, J. N. & Lewis, M. L. (1997). In-vitro studies of activities of the antifungal triazole SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrobial Agents and Chemotherapy41, 180\u20133.","DOI":"10.1128\/AAC.41.1.180"},{"key":"key\n\t\t\t\t20170411034910_R4","doi-asserted-by":"crossref","unstructured":"Law, D., Moore, C. B. & Denning, D. W. (1997). Activity of SCH56592 compared with those of fluconazole and itraconazole against Candida spp. Antimicrobial Agents and Chemotherapy41, 2310\u20131.","DOI":"10.1128\/AAC.41.10.2310"},{"key":"key\n\t\t\t\t20170411034910_R5","doi-asserted-by":"crossref","unstructured":"Tanaka, K., Miyazaki, T., Maesaki, S., Mitsutake, K., Kakeya, H., Yamamoto, Y. et al. (1996). Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis. Journal of Clinical Microbiology34, 2826\u20138.","DOI":"10.1128\/JCM.34.11.2826-2828.1996"},{"key":"key\n\t\t\t\t20170411034910_R6","unstructured":"The Guidelines of the Laboratory Animal Center for Biomedical Research, Nagasaki University School of Medicine. (1995)."},{"key":"key\n\t\t\t\t20170411034910_R7","doi-asserted-by":"crossref","unstructured":"Hossain, M. A., Maesaki, S., Kakeya, H., Noda, T., Yanagihara, K., Sasaki, E. et al. (1998). Efficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformans.Antimicrobial Agents and Chemotherapy42,1722\u2013 5.","DOI":"10.1128\/AAC.42.7.1722"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/44\/6\/827\/13057243\/JAC446827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T03:24:28Z","timestamp":1583292268000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/44.6.827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":7,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12]]},"published-print":{"date-parts":[[1999,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/44.6.827","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}